Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | China | 26 Jan 2022 | |
Neoplasms | Preclinical | China | 26 Jan 2022 |